The Company entered into a Subscription Agreement (the “Subscription Agreement”), dated as of August 3, 2009 (the “Closing Date”), with three investors, pursuant to which it sold an aggregate of One Million Dollars of its principal amount of secured convertible notes (the “Notes”). On the Closing Date the Company received gross proceeds of $500,000 and $500,000 (the “Escrowed Funds”) was placed in escrow pursuant to an Escrow Agreement between the Company, the Subscribers and Grushko & Mittman, as escrow agent. The Company paid the placement agent in the transaction $50,000 in fees. Pursuant to the Subscription Agreement, the Company had to file a preliminary proxy statement with the Securities and Exchange Commission by September 2, 2009 seeking approval for the transactions contemplated by the Subscription Agreement and the Company must obtain approval of its shareholders within 90 days of the Closing Date (125 days if the SEC reviews the proxy statement.). On September 24, 2009, the Company’s shareholders approved the transaction (the “Shareholder Approval”) and the Escrowed Funds were released. After the payment of fees in the amount of $50,000 to to the placement agent in the transaction, the Company received net proceeds of $450,000 (prior to the deduction of other fees and expenses related to the offering).
The initial interest rate of the Notes was 4% and after the Shareholder Approval, it became 8% per annum. Interest on the notes accrues from the date of the Closing Date is payable quarterly, in arrears, commencing six months after the Closing Date and on the maturity date of the Note. The Conversion Price of the Notes is the lesser of $.78 (the “Fixed Conversion Price”) as may be adjusted (the “Initial Conversion Price”). Commencing six months after the Closing Date, the Conversion Price shall be the lesser of the Fixed Conversion Price or 75% of the lowest three closing bid prices for the Company’s common stock for the ten days prior to when the Note is converted.
The Company also issued the Subscribers Class A Warrants to purchase 2,564,103 shares of the Company’s Common Stock at $1.12 per share. The Class A warrants are exercisable for a period beginning on August 3, 2009 and terminate on August 3, 2014.
Pursuant to the Subscription Agreement, the Company also issued the Subscribers a total of 40,000 class B Warrants. The Class B Warrants entitles the Subscribers at any time after the sooner of six months from the Closing Date or after the Company obtains the Shareholder Approval, until July 3, 2012, to purchase up to $4,000,000 of principal amount of the Company’s 8% notes on the same terms as the Notes. Upon the exercise of the Class B Warrants, the holder of the Class B Warrant will be issued two Class C Warrants for Each share of the Company’s common stock that would be issued on the exercise date of the Class B Warrant assuming the full conversion of the notes issued on such date. For each $100,000 of principal of notes purchased pursuant to the Class B Warrants, the Subscribers will surrender 1,000 Class B Warrants.
The Notes cannot be converted to the extent such conversion would cause the Subscriber, together with such holder’s affiliates, to beneficially own in excess of 4.99% of the of the Company’s outstanding common stock immediately following such conversion.
The Company also entered into a Security Agreement pursuant to which it granted the Subscribers a security interest in its assets. The security interest granted pursuant to the Security Agreement will terminate when the Approval is obtained or the Notes (including outstanding interest due thereon) are repaid.
In connection with the transaction, the Company issued the placement agent (or its employees) warrants to purchase 256,410 shares of the Company’s common stock.
The issuance and sale of the Notes and warrants pursuant to the Subscription Agreement was made in reliance upon the exemption provided in Section 4(2) of the Securities Act and Regulation D promulgated under the Securities Act. No form of general solicitation or general advertising was conducted in connection of the Private Placement. The issuance of the warrant to the selling agent (including its employees and affiliates) was made in reliance upon the exemption provided in Section 4(2) of the Securities Act.
Product revenue for the fiscal year ended July 31, 2009 totaled $1,485,298 an increase of 21.7% or $264,305 from the product revenue reported for the fiscal year ended July 31, 2008 of $1,220,993. The Company attributes this increase in revenues to long-term contract awards received during this fiscal year. Deliveries on these contracts began in early 2009.
Product cost (Material and Direct labor) for the fiscal year ended July 31, 2009 amounted to $470,392 or 31.7% of product revenues. Product cost for the fiscal year ended July 31, 2008 amounted to $467,081 or 38.2% of product revenues. The Company attributes the decrease in the current year’s product cost as a percentage of revenue and corresponding increase in the current year’s Gross Profit of $373,165 to the standardizing of costs to build our new PDR-2000 system and the outsourcing of assemblies.
For fiscal year ended July 31, 2009 the Company expensed $82,138 in obsolete inventory parts. This compares to $112,171 of obsolete inventory parts expensed during the fiscal year July 31, 2008.
Total Operating expenses for fiscal July 31, 2009 were $2,672,943 a decrease of $1,700,135 from $4,373,078 reported for fiscal July 31, 2008. The Company attributes this decrease to forgiveness of Officers Salary, reduced legal fees and a decrease in the value of stock compensation costs.
Other expenses for the fiscal year ended July 31, 2009 decreased by $2,540,274 to $695,995 from $3,236,269 for fiscal July 31, 2008. Included in this current years’ expense is a non-cash expense related to the induced conversion benefit of $552,370; a non-cash interest expense related to conversion of debt for $286,584 and the amortization of fees related to the conversion of debt for $123,274.
As a result of the foregoing, the Company reported a net loss applicable to common shares of $2,354,032 or $0.98 per share for fiscal 2009, compared to a net loss applicable to common shares of $6,967,606 or $23.49 per share (as restated for the stock reversal for fiscal 2009).
LIQUIDITY AND CAPITAL RESOURCES
Working capital at July 31, 2009 was $2,028,582 compared to $2,049,641 at year ended July 31, 2008.
Accounts receivable have decreased from $360,846 at July 31, 2008 to $245,980 at July 31, 2009. This decrease of $114,866 is the result of delay by customers in accepting shipments.
The Company expects to meet its cash requirements for the next twelve months through existing cash balances and cash generated from operations. However, we anticipate that we may require additional financing to expand our operations. We cannot guarantee that we will be able to obtain any additional financing or that such additional financing, if available, will be on terms and conditions acceptable to us. The inability to obtain additional financing should it be required will restrict our ability to grow and may reduce our ability to continue to conduct business operations. If we are unable to obtain additional financing, we will likely be required to curtail our development plans.
INFLATION
Management believes that the results of operations have not been affected by inflation and management does not expect inflation to have a significant effect on its operations in the future.
CRITICAL ACCOUNTING POLICIES
The Company’s consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, at the date of the financial statements and reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management uses its best judgment in valuing these estimates and may, as warranted, solicit external professional advice and other assumptions believed to be reasonable. The following critical accounting policies, some of which are impacted significantly by judgments, assumptions and estimates, affect the Company’s consolidated financial statements.
INCOME RECOGNITION
Revenue is recorded in accordance with the guidance of the SEC’s Staff Accounting Bulletin (SAB) No. 104, which supersedes SAB No. 101.Revenue from product sales are recognized at the time of shipment (when title has passed) upon fulfillment of acceptance terms; products are not sold on a conditional basis. Therefore, when delivery has occurred the sale is complete as long as the collection of the resulting receivable is probable.
RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
The preparation of financial statements requires our management to make estimates and assumptions relating to the collectivity of our accounts receivable. Management specifically analyzes historical bad debts, customer credit worthiness, current economic trends and changes in our customer payment terms when evaluating the adequacy of the allowance for doubtful accounts. The Company has a concentration risk in trade accounts receivable with significant sales to the government and local agencies. The credit evaluation process has mitigated the credit risk, such losses have been minimal, and within management expectations.
INVENTORY VALUATIONS, COMPONENTS AND AGING
Inventories are valued at the lower cost or market. Determined by a first-in, first-out (“FIFO”) method.The Company’s products are used in radio and other transmissions, telephone and telephone exchanges, air and traffic controls, automatic transmission of data for utilities, tele-printing of transmission data such as news and stock market information and for use by electric utilities in monitoring power transmissions lines for faults and/or failures.
The Company currently manufactures and supports over 400 products and assemblies that have been in the market place since 1970. The Company’s inventory represents approximately 10,000 different components and 2,500 assemblies. The Company presents its inventory in three categories, Finished Goods, Work-in-Process and Raw Materials. Finished Goods represents products that have been completed in connection with specific orders and are awaiting shipment. Finished Goods can consist of produces like the PDR-2000, PTR-1500 and 1000, Gen 1, 98 and 68 series. Work-in-Process represents components that have been requisitioned from the warehouse and are being assembled in the assembly areas. Depending on the configurations required by a customer, products are completed and tested within 8 to 10 business days. Raw Materials represent components in their
18
original packaging stored in a secured warehouse area, and may consist, in part, of Face plates, PC boards, Digital screen assemblies, Guide rails, Capacitors, Terminals, Power supplies, Process ships, Chassis and racks, Relays, Keypads and Resistors.
The Company provides a twelve-year warranty on all commercial products and is required by Government regulation to design and produce military products with a minimum 25-year operating life in addition to shelf life.
Every component, regardless of age, has been purchased to meet the above criteria and may be used in any and all above said assemblies. Management believes that this inventory, which is minimally adequate, is required to implement the Company’s commitments to military requirements for present and delivered orders.
The Company, following inventory analysis and repeated annual testing, established a 3-year rule for maintaining inventory, which requires a write-down policy for inventory parts depending on their age. The inventory is tested annually applying its 3-year rule and the Company classifies as current assets only that amount of inventory it expects to realize in the next one-year operating cycles, any balance of the inventory is classified as non-current. Any parts which have not been used for 3 years are valued at zero. Any parts, written down to a zero value under the 3-year rule, are maintained in inventory to satisfy the requirements under our long-term warranty programs.
WARRANTY
The Company provides a twelve-year warranty on its products; the warranty covers parts and labor. The Company, at its option, repairs or replaces products that are found defective during the warranty period providing proper preventive maintenance procedures have been followed by customers. Repairs necessitated by misuse of such products are not covered by our warranty. In cases of defective products, the customer typically returns them to the Company’s facility in Somerville, New Jersey. The Company’s service personnel will replace or repair the defective items and ship them back to the customer. All servicing is completed at the Company’s main facility and customers are charged a fee for those service items that are not covered by the warranty. We do not offer our customers any formal written service contracts.
INCOME TAXES
Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the bases of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future federal and state income taxes.
OFF BALANCE SHEET ARRANGEMENTS
Not applicable.
Penny Stock Rules
Our shares of Common Stock are subject to the “penny stock” rules of the Securities Exchange Act of 1934 and various rules under this Act. In general terms, “penny stock” is defined as any equity security that has a market price less than $5.00 per share, subject to certain exceptions. The rules provide that any equity security is considered to be a penny stock unless that security is registered and traded on a national securities exchange meeting specified criteria set by the SEC, authorized for quotation from the NASDAQ stock market, issued by a registered investment company, and excluded from the definition on the basis of price (at least $5.00 per share), or based on the issuer’s net tangible assets or revenues. In the last case, the issuer’s net tangible assets must exceed $3,000,000 if in continuous operation for at least three years or $5,000,000 if in operation for less than three years, or the issuer’s average revenues for each of the past three years must exceed $6,000,000.
Trading in shares of penny stock is subject to additional sales practice requirements for broker-dealers who sell penny stocks to persons other than established customers and accredited investors. Accredited investors, in general, include individuals with assets in excess of $1,000,000 or annual income exceeding $200,000 (or $300,000 together with their spouse), and certain institutional investors. For transactions covered by these rules, broker-dealers must make a special suitability determination for the purchase of the security and must have received the purchaser’s written consent to the transaction prior to the purchase. Additionally, for any transaction involving a penny stock, the rules require the delivery, prior to the first transaction, of a risk disclosure document relating to the penny stock. A broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, and current quotations for the security. Finally, monthly statements must be sent disclosing recent price information for the penny stocks. These rules may restrict the ability of broker-dealers to trade or maintain a market in our common stock, to the extent it is penny stock, and may affect the ability of shareholders to sell their shares.
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDERS MATTERS AND
ISSUER PURCHASERS OF EQUITY SERCURITIES AND SMALL ISSUER PURCHASE OF
EQUITY SECURITIES
19
MARKET FOR OUR COMMON STOCK
AND RELATED
STOCKHOLDER MATTERS
Our Common Stock is traded on the Nasdaq Capital Market, under the symbol CNLG. The following table sets forth the range of high and low bid quotations of our common stock for the periods indicated.
| | | | | | | |
| | Common Stock | |
First Quarter | | High | | Low | |
| |
| |
| |
| | | | | | | |
Ended October 31, 2009 | | $ | 3.14 | | $ | 0.97 | |
| | | | | | | |
Fiscal Year 2009 | | High | | Low | |
| |
| |
| |
| | | | | | | |
First Quarter | | $ | 5.85 | | $ | 1.85 | |
second Quarter | | $ | 3.15 | | $ | 1.25 | |
Third Quarter | | $ | 3.00 | | $ | 1.37 | |
Fourth Quarter | | $ | 2.29 | | $ | 1.15 | |
| | | | | | | |
| | Common Stock | |
|
Fiscal Year 2008* | | High | | Low | |
| |
| |
| |
| | | | | | | |
First Quarter | | $ | 11.12 | | $ | 5.68 | |
second Quarter | | $ | 7.36 | | $ | 3.48 | |
Third Quarter | | $ | 4.22 | | $ | 2.80 | |
Fourth Quarter | | $ | 3.16 | | $ | 0.84 | |
* Represents retroactive application of 1:5 reverse stock split.
As of July 31, 2009, the Company’s Common Stock was held by approximately 450 shareholders of record. Our transfer agent is Continental Stock Transfer & Trust Company, with offices at 17 Battery Place, 8th floor, New York, New York, telephone number (212) 509-4000. As transfer agent for our shares of common stock the transfer agent is responsible for all record-keeping and administrative functions in connection with the common shares of stock.
Dividends. Holders of Common Stock are entitled to receive such dividends as may be declared by the Board of Directors of the Company. To date, the Company has neither declared nor paid any dividends on its Common Stock or on its Preferred A or
20
Preferred B shares. The Company anticipates that no such dividends will be paid in the foreseeable future. Rather, the Company intends to apply any earnings, if any, to the expansion and development of its business. Any payment of cash dividends on any of its securities in the future will be dependent upon the future earnings of the Company, including its financial condition, capital requirement and other factors, which the Board of Directors deems relevant.
EQUITY COMPENSATION PLAN INFORMATION
The following table sets forth the information indicated with respect to our compensation plans under which our common stock is authorized for issuance.
| | | | | | | |
|
|
| | Number of Securities to be issued upon exercise of outstanding options, warrants and rights (a) | | Weighted average exercise price of outstanding options, warrants and rights (b) | | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) | |
|
Equity compensation plans approved by security holders | | On July 9, 2002 our stockholders approved our 2002 Stock Option Plan under which up to 190,000 shares of our common stock may be granted to our employees, directors and consultants. To date, no options have been granted under this plan. The exercise price of options granted under the 2002 Stock Option Plan will be the fair market value of our common stock on the date immediately preceding the date on which the option is granted. | | N/A | | 190,000 | |
|
| | | | | | | |
Equity compensation plans not approved by security holders | | N/A | | | | | |
|
| | | | | | | |
Total | | 190,000 | | | | | |
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
21
DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS
The following table sets forth certain information regarding the officers and directors of the Company.
| | | | |
Name | | Age | | Position |
| |
| |
|
Robert S. Benou | | 74 | | Chairman, Chief Executive Officer, Chief Financial Officer and Director |
| | | | |
Marc R. Benou | | 40 | | President, Chief Operating Officer, Secretary and Director |
| | | | |
Louis S. Massad | | 72 | | Director |
| | | | |
Edward J. Rielly | | 40 | | Director |
| | | | |
David M. Peison | | 40 | | Director |
| | | | |
Thomas Fogg | | 72 | | Officer, Vice President-Engineering |
Robert S. Benou
Robert S. Benou has been the Company’s Chairman and Chief Executive Officer since May 1, 2001. He is also the Company’s Chief Financial Officer. From 1968 until May 1, 2001, he served as the Company’s President. Mr. Benou is responsible for material purchasing and inventory control. From June 2001 until August 2005, Mr. Benou served as a director of Henry Bros. Electronics, Inc. (formerly known as Diversified Security Solutions, Inc.), a publicly held company that is a single-source/turn-key provider of technology-based security solutions for medium and large companies and government agencies. Mr. Benou is also served as a member of the Board of Directors of eXegenics Inc. from February 2004 to December 2006. The common stock of eXegenics Inc. is traded on the OTC Bulletin Board. Mr. Benou is a graduate of Victoria College and holds a BS degree from Kingston College, England and a BSEE from Newark College of Engineering, in addition to industrial management courses at Newark College of Engineering. Robert S. Benou is the father of Marc R. Benou.
Marc R. Benou
Marc R. Benou has been the Company’s President and Chief Operating Officer since May 1, 2001. Mr. Benou joined the Company in 1991 and is responsible for new product development and supervision of sales and marketing. From March 1995 until May 1, 2001, he served as Vice President. Mr. Benou has been on the company’s Board and has served as the Company’s assistant secretary since March 1995. Mr. Benou attended Lehigh and High Point University and holds a BS degree in Business Administration and Management. Marc R. Benou is the son of Robert S. Benou, the Company’s Chairman and Chief Executive Officer.
Louis S. Massad
Louis S. Massad has been a Director of the Company since April 1995. Mr. Massad was Chief Financial Officer and a Director of Henry Bros. Electronics, Inc. (formerly known as Diversified Security Solutions, Inc.), from 2000 until August 2003. From 1997 to 2000, Mr. Massad was a consultant to Diversified Security Solutions, Inc. From 1986 to 1997, Mr. Massad was a Vice President, Chief Financial Officer and Director of Computer Power Inc. Mr. Massad holds a BS and MS degree from Cairo University (Egypt) and an MBA from Long Island University, New York.
Edward J. Rielly
Edward J. Rielly has been a Director of the Company since January 1998. Mr. Rielly is a Senior Application Developer with Household International, a financial corporation. From March 2000 to November 2001, Mr. Rielly was a Senior Consultant with Esavio Corporation. From February 1998 to February 2000, Mr. Rielly was an Application Developer with Chubb Corporation. From 1993 to 1998, Mr. Rielly was an Application Developer with the United States Golf Association. Mr. Rielly is a graduate of Lehigh University and holds a BS in Computer Science.
Thomas R. Fogg
Thomas R. Fogg joined the Company in 1976 as Chief Engineer responsible for analog and guidance projects. Since 1986, Mr. Fogg has served as Vice President-Engineering; he led the design team in the development of the Company’s commercial products. Mr. Fogg holds a BSEE degree from Lafayette College and a MSEE degree from Rutgers University. Mr. Fogg is a fellow of the Institute of Electrical and Electronic Engineers and has published articles on delay equalization and the use of crystal resonators.
David M. Peison
David M. Peison has been a Director of the Company since October 2004. Since 2005, Mr. Peison has been vice president with
22
the emerging markets division of HSBC. From 2002 until 2005, Mr. Peison was with Deutsche Bank’s global markets division in New York City. From 1992 to 2000, Mr. Peison was in a Private Law Practice in Florida and New York City. Mr. Peison holds an MBA from Emory University in Atlanta, Ga., a JD from The Dickinson School of Law of Pennsylvania State University and is admitted to Florida, New York and Massachusetts Bars. Mr. Peison obtained his BA degree from Lehigh University in Bethlehem, Pa.
Directors hold office until the annual meeting of the Company’s stockholders and the election and qualification of their successors. Officers hold office, subject to removal at anytime by the Board, until the meeting of directors immediately following the annual meeting of stockholders and until their successors are appointed and qualified.
Audit Committee
The Company’s Board of Directors has determined that David M. Peison is the Audit Committee’s Financial Expert and that he is “independent” defined under National Association of Securities Dealers Automated Quotations system.
The Company has a standing Audit Committee, the members of which are, Louis Massad, Edward J. Rielly and David M. Peison.
Changes in Nominating Procedures
None
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth, as of October 31, 2009, certain information with respect to the beneficial ownership of our common stock by each stockholder known by us to be the beneficial owner of more than 5% of our common stock and by each of our current directors and executive officers. Each person has sole voting and investment power with respect to the shares of common stock, except as otherwise indicated.
This table is prepared based on information supplied to us by the listed security holders, any Schedules 13D or 13G and Forms 3 and 4, and other public documents filed with the SEC.
Under the rules of the Securities and Exchange Commission, a person is deemed to be a beneficial owner of a security if that person has or shares voting power, which includes the power to vote or direct the voting of the security, or investment power, which includes the power to vote or direct the voting of the security. The person is also deemed to be a beneficial owner of any security of which that person has a right to acquire beneficial ownership within 60 days. Under the Securities and Exchange Commission rules, more than one person may be deemed to be a beneficial owner of the same securities, and a person may be deemed to be a beneficial owner of securities as to which he or she may not have any pecuniary beneficial interest.
Unless otherwise noted, the address for each of the named individuals is c/o Conolog Corporation, 5 Columbia Road, Somerville, New Jersey 08876.
Shares of common stock which an individual or group has a right to acquire within 60 days pursuant to the exercise or conversion of options are deemed to be outstanding for the purpose of computing the percentage ownership of such individual or group, but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person shown in the table. The applicable percentage of ownership at October 31, 2009 is based on 3,180,846 shares issued and outstanding.
23
| | | | | | | |
Name and Title | | Amount and Nature of Beneficial Ownership | | Percent of Class | |
| |
| |
| |
Robert S. Benou, Chairman, Chief Executive Officer Chief Financial Officer and Director | | | 592,667 | | | 18.60 | % |
| | | | | | | |
Marc R. Benou, President, Chief Operating Officer, Secretary and Director | | | 521,223 | | | 16.40 | % |
| | | | | | | |
Louis Massad, Director | | | 37,500 | | | 1.20 | % |
| | | | | | | |
Edward J. Rielly, Director | | | 37,500 | | | 1.20 | % |
| | | | | | | |
David M. Peison, Director | | | 37,500 | | | 1.20 | % |
| | | | | | | |
Thomas Fogg, Vice President -Engineering | | | 30,000 | | | .90 | % |
| | | | | | | |
| |
|
| |
|
| |
All Officers and Directors as a Group (6 persons) | | | 1,256,390 | | | 39.50 | % |
COMPENSATION OF EXECUTIVE OFFICERS
The following table sets forth the total compensation paid to and accrued by each executive officer during the prior three fiscal years.
| | | | | | | | | | | | | | | | | | | | | | |
Annual Compensation | | Long-Term Compensation | |
| |
| |
Name & Title | | Year- End July 31st | | Salary | | Bonus | | Restricted Stock Award | | Closing Price On the Date of Restricted Stock Award | | Securities Underlying Option/ SARS | | Other* | |
| |
| |
| |
| |
| |
| |
| |
| |
| | | | | | | | | | | | | | | | | | | | | | |
Robert Benou, Chairman | | | 2009 | | $ | 110,833 | (4) | $ | 0 | | | 0 | | $ | 0 | | | — | | $ | 16,000 | |
| | | | | | | | | | | | | | | | | | | | | | |
Chief Executive Officer | | | 2008 | | $ | 348,333 | | $ | 70,000 | (1) | | 237,500 | (3) | $ | 0.67 | | | — | | $ | 21,500 | |
| | | | | | | | | | | | | | | | | | | | | | |
CFO and Director | | | 2007 | | $ | 337,300 | | $ | 150,000 | | | 144,000 | | $ | 0.41 | | | — | | $ | 18,000 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | | | | | | | | | | | | | | | | | | | | | |
Marc Benou, President | | | 2009 | | $ | 208,516 | | $ | 0 | | | 0 | | $ | 0 | | | — | | $ | 0 | |
| | | | | | | | | | | | | | | | | | | | | | |
Chief Operating Officer | | | 2008 | | $ | 173,949 | | $ | 40,000 | (2) | | 237,000 | (3) | $ | 0.67 | | | — | | $ | 0 | |
| | | | | | | | | | | | | | | | | | | | | | |
Secretary and Director | | | 2007 | | $ | 143,625 | | $ | 100,000 | | | 140,000 | | $ | 0.41 | | | — | | $ | 0 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | | | | | | | | | | | | | | | | | | | | | |
Thomas Fogg | | | 2009 | | $ | 43,040 | | $ | 0 | | | 0 | | $ | 0 | | | — | | $ | 0 | |
| | | | | | | | | | | | | | | | | | | | | | |
Vice-President | | | 2008 | | $ | 43,040 | | $ | 0 | | | 25,000 | (3) | $ | 0.67 | | | — | | $ | 0 | |
| | | | | | | | | | | | | | | | | | | | | | |
Engineering | | | 2007 | | $ | 40,602 | | $ | 0 | | | 10,000 | | $ | 0.41 | | | — | | $ | 0 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Other compensation consisted of a car allowance.
| |
1. | The Company paid Robert Benou’s 2008 bonus by July 31, 2008. |
| |
2. | The Company paid Marc Benou’s bonus by July 31, 2008. |
| |
3. | On May 21, 2008, our stockholders approved the granting of 800,000 shares of our common stock to our directors, officers and employees. |
| |
4. | During fiscal 2009, Robert Benou forgave $286,467 of his salary. |
24
Outstanding equity awards at fiscal year end.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Name | | Option Awards | | Stock Awards | |
| |
| |
| |
| | Number of Securities Underlying Unexercised Options (#) Exercisable | | Number of Securities Underlying Unexercised Options (#) Unexercisable | | Equity Incentive Plan Awards: Number of Securities Underlying of Unexercised Unearned Options (#) | | Option Exercise Price ($) | | Option Expiration Date | | Number of Shares or Units of Stock That Have Not Vested (#) | | Market Value of Shares or Units of Stock That Have Not Vested ($) | | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#) | | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
Robert Benou | | | 0 | | | 0 | | | 0 | | | 0 | | | 0 | | | 221,000 | | | 221,000 | | | 0 | | | 0 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marc Benou | | | 0 | | | 0 | | | 0 | | | 0 | | | 0 | | | 230,000 | | | 230,000 | | | 0 | | | 0 | |
On July 9, 2002 our stockholders approved our 2002 Stock Option Plan under which up to 190,000 shares of our common stock may be granted to our employees, directors and consultants. To date, no options have been granted under this plan. The exercise price of options granted under the 2002 Stock Option Plan will be the fair market value of our common stock on the date immediately preceding the date on which the option is granted.
EMPLOYMENT AGREEMENTS
EMPLOYMENT AGREEMENTS
Mr. Robert Benou is serving under an employment agreement commencing June 1, 1997 and ending May 31, 2002, which pursuant to its terms, renews for one-year terms until cancelled by either the Company or Mr. Benou. Mr. Benou’s annual base salary as of July 31, 2009 was $397,300 and increases by $20,000 annually on June 1st of each year. In addition, Mr. Benou is entitled to an annual bonus equal to 6% of the Company’s annual “income before income tax provision” as stated in its annual Form 10-K. The employment agreement also entitles Mr. Benou to the use of an automobile and to employee benefit plans, such as; life, health, pension, profit sharing and other plans. Under the employment agreement, employment terminates upon death or disability of the employee and the employee may be terminated by the Company for cause.
Mr. Marc Benou is serving under an employment agreement commencing June 1, 1997 and ending May 31, 2002, which pursuant to its terms, renews for one-year terms until cancelled by either the Company or Mr. Benou. Mr. Benou’s annual base salary as of July 31, 2009 was $203,700 and he receives annual increases of $12,000 on June 1st of each year. Mr. Benou is entitled to an annual bonus equal to 3% of the Company’s annual “income before income tax provision” as stated in its annual Form 10-K. The employment agreement also entitles Mr. Benou to the use of an automobile and to employee benefit plans, such as; life, health, pension, profit sharing and other plans. Under the employment agreement, employment is terminated upon death or disability of the employee and employee may be terminated by the Company for cause.
COMPENSATION OF DIRECTORS
No director of the Company receives any cash compensation for his services as such, but directors may receive stock options pursuant to the Company’s stock option plan and grants of the Company’s common stock. Currently, the Company has three
25
directors who are not employees, Messrs. Louis Massad, David Peison and Edward Rielly. The following table summarizes the compensation for our non-employee directors for the fiscal year ended July 31, 2009.
DIRECTOR COMPENSATION
The following table represents a summary of the compensation paid to our directors for their services on our board of directors during the fiscal year ended July 31, 2009. Except as listed below, during the fiscal year ended July 31, 2009, there were no bonuses, other annual compensation, restricted stock awards or stock options/SARs, or any other compensation paid to the directors listed for their services as a director of the Company.
Directors Compensation for the Fiscal Year Ended July 31, 2009
| | | | | | | | | | |
Name | | Cash | | Stock Awards Awards ($) | | Total ($) | |
| |
| |
| |
| |
Robert S. Benou | | $ | 0 | | $ | 0 | | $ | 0 | |
Marc Benou | | $ | 0 | | $ | 0 | | $ | 0 | |
Louis S. Massad | | $ | 0 | | $ | 65,100 | | $ | 65,100 | |
Edward J. Rielly | | $ | 0 | | $ | 65,100 | | $ | 65,100 | |
David M. Peison | | $ | 0 | | $ | 65,100 | | $ | 65,100 | |
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
Certain Relationships and Related Transactions
None
Board determination of Independence
Messrs. Massad, Rielly and Peison are each “independent” as that term is defined under the National Association of Securities Dealers Automated Quotation system.
ADDITIONAL INFORMATION
Federal securities laws require us to file information with the Commission concerning our business and operations. Accordingly, we file annual, quarterly, and special reports, and other information with the Commission. You can inspect and copy this information at the public reference facility maintained by the Commission at 100 F Street, NE, Washington, D.C. 20549.
You can get additional information about the operation of the Commission’s public reference facilities by calling the Commission at 1-800-SEC-0330. The Commission also maintains a web site (http://www.sec.gov) at which you can read or download our reports and other information.
We have filed with the Commission a registration statement on Form S-1 under the Securities Act of 1933 with respect to the common stock being offered hereby. As permitted by the rules and regulations of the Commission, this prospectus does not contain all the information set forth in the registration statement and the exhibits and schedules thereto. For further information with respect to and the common stock offered hereby, reference is made to the registration statement, and such exhibits and schedules. A copy of the registration statement, and the exhibits and schedules thereto, may be inspected without charge at the public reference facilities maintained by the Commission at the addresses set forth above, and copies of all or any part of the registration statement may be obtained from such offices upon payment of the fees prescribed by the Commission. In addition, the registration statement may be accessed at the Commission’s web site.
26
DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES
Our Certificate of Incorporation provides that we shall, to the fullest extent permitted by Section 145 of the Delaware General Corporation Law, as amended from time to time, indemnify all persons whom it may indemnify pursuant thereto.
Section 145 of the General Corporation Law of the State of Delaware authorizes a corporation to provide indemnification to a director, officer, employee or agent of the corporation, including attorneys’ fees, judgments, fines and amounts paid in settlement, actually and reasonably incurred by him in connection with such action, suit or proceeding, if such party acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful as determined in accordance with the statute, and except that with respect to any action which results in a judgment against the person and in favor of the corporation the corporation may not indemnify unless a court determines that the person is fairly and reasonably entitled to the indemnification. Section 145 further provides that indemnification shall be provided if the party in question is successful on the merits.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or controlling persons of the Company, pursuant to the foregoing provisions, or otherwise, the Company has been advised that, in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered hereunder, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
LEGAL MATTERS
The validity of the shares offered hereby will be passed upon for us by Sichenzia Ross Friedman Ference LLP, 61 Broadway, New York, New York 10006.
EXPERTS
Bagell, Josephs, Levine & Company, L.L.C., an independent registered public accounting firm, located at 406 Lippincott Drive, Suite 6, Marlton, New Jersey 08053 have audited our Financial Statements included in this registration statement to the extent, and for the periods set forth in their reports. We have relied upon such reports, given upon the authority of such firm as experts in accounting and auditing.
INTERESTS OF NAMED EXPERTS AND COUNSEL
No expert or counsel named in this prospectus as having prepared or certified any part of this prospectus or having given an opinion upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering of the common stock was employed on a contingency basis or had, or is to receive, in connection with the offering, a substantial interest, directly or indirectly, in the registrant or any of its parents or subsidiaries, provided that Sichenzia Ross Friedman Ference LLP and/or certain members or employees of Sichenzia Ross Friedman Ference LLP have received shares of the Company’s Common Stock.
27
Consolidated Financial Statements
July 31, 2009 and 2008
Conolog Corporation and Subsidiaries
Somerville, New Jersey
Index to the Consolidated Financial Statements
Conolog Corporation and Subsidiaries
July 31, 2009 and 2008
BAGELL, JOSEPHS, LEVINE & COMPANY, L.L.C.
Certified Public Accountants
Suite J
406 Lippincott Drive
Marlton, New Jersey 08053
(856) 355-5900 Fax (856) 396-0022
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Board of Directors
Conolog Corporation
Somerville, New Jersey
We have audited the accompanying consolidated balance sheets of Conolog Corporation and Subsidiaries (the “Company”) as of July 31, 2009 and 2008, and the related consolidated statements of operations, stockholders’ equity and cash flows for each of the years in the two year period ended July 31, 2009. The Company’s management is responsible for these consolidated financial statements. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Conolog Corporation and Subsidiaries as of July 31, 2009 and 2008, and the consolidated results of its operations and cash flows for each of the years in the two year period ended July 31, 2009, in conformity with accounting principles generally accepted in the United States of America.
BAGELL, JOSEPHS, LEVINE & COMPANY, L.L.C.
BAGELL, JOSEPHS, LEVINE & COMPANY, L.L.C.
Certified Public Accountants
Marlton, New Jersey
NOVEMBER 12, 2009
F-1
CONOLOG CORPORATION AND SUBSIDARIES
CONSOLIDATED BALANCE SHEETS
JULY 31, 2009 AND 2008
| | | | | | | | |
ASSETS | | | | | | | | |
| | 2009 | | | 2008 | |
| | | | | | |
Current Assets: | | | | | | | | |
Cash and cash equivalents | | $ | 27,358 | | | $ | 680,647 | |
Certificate of deposit | | | - | | | | 600,182 | |
Accounts receivable, net of allowance | | | 245,980 | | | | 360,846 | |
Prepaid expenses and consulting fees | | | 70,843 | | | | 46,367 | |
Current portion of note receivable | | | 14,864 | | | | 14,864 | |
Inventory | | | 1,395,452 | | | | 850,507 | |
Other current assets | | | 551,937 | | | | 568,529 | |
| | | | | | | | |
| | | | | | | | |
Total Current Assets | | | 2,306,434 | | | | 3,121,942 | |
| | | | | | | | |
| | | | | | | | |
Property and equipment: | | | | | | | | |
Machinery and equipment | | | 1,357,053 | | | | 1,357,053 | |
Furniture and fixtures | | | 429,765 | | | | 429,765 | |
Automobiles | | | 34,097 | | | | 34,097 | |
Computer software | | | 520,622 | | | | 209,380 | |
Leasehold improvements | | | 30,265 | | | | 30,265 | |
| | | | | | | | |
Total property and equipment | | | 2,371,802 | | | | 2,060,560 | |
Less: accumulated depreciation | | | (1,975,098 | ) | | | (1,951,725 | ) |
| | | | | | | | |
Net Property and Equipment | | | 396,704 | | | | 108,835 | |
| | | | | | | | |
| | | | | | | | |
Other Assets: | | | | | | | | |
Deferred financing fees, net of amortization | | | 8,445 | | | | 295,030 | |
Note receivable, net of current portion | | | 69,846 | | | | 80,495 | |
| | | | | | | | |
| | | | | | | | |
Total Other Assets | | | 78,291 | | | | 375,525 | |
| | | | | | | | |
| | | | | | | | |
TOTAL ASSETS | | $ | 2,781,429 | | | $ | 3,606,302 | |
| | | | | | | | |
The accompanying notes are an integral part of the consolidated financial statements
F-2
CONOLOG CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
JULY 31, 2009 AND 2008
| | | | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | |
| | 2009 | | | 2008 | |
| | | | | | |
Current Liabilities: | | | | | | | | |
Accounts payable | | $ | 217,456 | | | $ | 165,601 | |
Accrued expenses | | | 26,132 | | | | 61,957 | |
Current Convertible debenture, net of discount | | | 34,318 | | | | 824,853 | |
| | | | | | | | |
Total Current Liabilities | | | 277,906 | | | | 1,052,411 | |
| | | | | | | | |
| | | | | | | | |
Non-Current Liabilities: | | $ | - | | | $ | - | |
| | | | | | | | |
| | | | | | | | |
Total Liabilities | | | 277,906 | | | | 1,052,411 | |
| | | | | | | | |
| | | | | | | | |
Stockholders’ Equity: | | | | | | | | |
Preferred stock, par value $.50; Series A; 4% cumulative; 500,000 shares authorized; 155,000 shares issued and outstanding at July 31, 2009 and 2008, respectively. | | | 77,500 | | | | 77,500 | |
Preferred stock, par value $.50; Series B; $.90 cumulative; 500,000 shares authorized; 1,197 shares issued and outstanding at July 31, 2009 and 2008, respectively. | | | 597 | | | | 597 | |
Common stock, par value $0.01; 30,000,000 shares authorized; 1,842,485 and 558,488* shares issued and outstanding at July 31, 2009 and 2008 respectively including 2 shares held in treasury. | | | 18,425 | | | | 5,574 | * |
Contributed capital | | | 52,385,432 | | | | 50,025,998 | * |
Accumulated deficit | | | (49,173,964 | ) | | | (46,819,934 | ) |
Treasury shares at cost | | | (131,734 | ) | | | (131,734 | ) |
Deferred compensation | | | (672,733 | ) | | | (604,110 | ) |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Total Stockholders’ Equity | | | 2,503,523 | | | | 2,553,891 | |
| | | | | | | | |
| | | | | | | | |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 2,781,429 | | | $ | 3,606,302 | |
| | | | | | | | |
*Represents retroactive application of 1:5 reverse stock split.
The accompanying notes are an integral part of the consolidated financial statements.
F-3
CONOLOG CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| | | | | | | | |
| | 2009 | | 2008 | |
| | | | | | |
OPERATING REVENUES | | | | | | | | |
Product revenue | | $ | 1,485,298 | | | $ | 1,220,993 | |
| | | | | | | | |
| | | | | | | | |
Cost of product revenue | | | | | | | | |
Materials and labor used in production | | | 470,392 | | | | 467,081 | |
Write down of obsolete inventory parts | | | - | | | | 112,171 | |
| | | | | | | | |
Total Cost of product revenue | | | 470,392 | | | | 579,252 | |
| | | | | | | | |
| | | | | | | | |
Gross Profit (Loss) from Operations | | | 1,014,906 | | | | 641,741 | |
| | | | | | | | |
Selling, general and administrative expenses | | | | | | | | |
General and adminitsrative | | | 1,235,301 | | | | 2,094,819 | |
Stock compensation | | | 715,242 | | | | 1,319,400 | |
Stock compliance | | | 203,006 | | | | 230,396 | |
Research and development | | | 57,089 | | | | 150,173 | |
Professional fees | | | 291,741 | | | | 412,119 | |
Marketing and trade shows | | | 170,564 | | | | 166,171 | |
| | | | | | | | |
Total selling, general and admintrative expenses | | | 2,672,943 | | | | 4,373,078 | |
| | | | | | | | |
Loss Before Other Income (Expenses) | | | (1,658,037 | ) | | | (3,731,337 | ) |
| | | | | | | | |
OTHER INCOME (EXPENSES) | | | | | | | | |
Interest expense | | | (102,379 | ) | | | (77,922 | ) |
Interest income | | | 16,265 | | | | 92,485 | |
Other income | | | 352,347 | | | | 112,485 | |
Induced conversion cost | | | (552,370 | ) | | | (1,387,087 | ) |
Write off of discount on converted debt | | | - | | | | (864,892 | ) |
Amortization of deferred loan discount | | | (286,584 | ) | | | (606,598 | ) |
Amortization of deferred financing fees | | | (123,274 | ) | | | (504,740 | ) |
| | | | | | | | |
Total Other Income (Expense) | | | (695,995 | ) | | | (3,236,269 | ) |
| | | | | | | | |
Loss before provision for income taxes | | | (2,354,032 | ) | | | (6,967,606 | ) |
Provision for income taxes | | | - | | | | - | |
| | | | | | | | |
NET LOSS APPLICABLE TO COMMON SHARES | | $ | (2,354,032 | ) | | $ | (6,967,606 | ) |
| | | | | | | | |
NET LOSS PER BASIC AND DILUTED COMMON SHARE | | $ | (0.98 | ) | | $ | (23.49 | ) |
| | | | | | | | |
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING | | | 2,396,924 | | | | 296,676 | * |
| | | | | | | | |
*Represents retroactive application of 1:5 reverse stock split.
The accompanying notes are an integral part of the consolidated financial statements.
F-4
CONOLOG CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDER EQUITY
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Series A | | Series B | | | | | | | | Contributed | | | | | | | | | | Total | |
|
| | Preferred Stock | | Preferred Stock | | Common Stock | | Contributed | | Capital - | | Accumulated | | Treasury | | Deferred | | Prepaid | | Stockholders’ | |
|
| | Shares | | Amount | | Shares | | Amount | | Shares | | Amount | | Capital | | Warrants | | Deficit | | Stock | | Compensation | | Consulting | | Equity | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at July 31, 2007 | | 155,000 | | $ | 77,500 | | 1,197 | | $ | 597 | | 193,824 | * | $ | 1,938 | * | $ | 40,915,310 | * | $ | 3,857,593 | | $ | (39,852,326 | ) | $ | (131,734 | ) | $ | (1,319,400 | ) | $ | (120,600 | ) | $ | 3,549,478 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Conversion of convertible debenture | | | | | | | | | | | | 149,018 | * | | 1,490 | * | | 1,871,754 | * | | | | | | | | | | | | | | | | | 1,873,244 | |
Shares issued for services to be provided | | | | | | | | | | | | 5,000 | * | | 50 | * | | 19,840 | * | | | | | | | | | | | | | | (19,890 | ) | | 19,890 | |
Induced conversion cost | | | | | | | | | | | | | | | | | | 1,387,087 | * | | | | | | | | | | | | | | | | | 1,387,087 | |
Sale of Equity | | | | | | | | | | | | 47,650 | * | | 477 | * | | 1,333,723 | * | | | | | | | | | | | | | | | | | 1,334,200 | |
Interest paid with stock | | | | | | | | | | | | 7,001 | * | | 70 | * | | 38,128 | * | | | | | | | | | | | | | | | | | 38,198 | |
Common shares issued to officers, directors and employees for fiscal 2007 | | | | | | | | | | | | 154,900 | * | | 1,549 | * | | 602,561 | * | | | | | | | | | | | (604,110 | ) | | | | | - | |
Amortization officers, directors and employee compensation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1,319,400 | | | | | | 1,319,400 | |
Net loss for the Year | | | | | | | | | | | | | | | | | | | | | | | | (6,967,606 | ) | | | | | | | | | | | (6,967,606 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at July 31, 2008 | | 155,000 | | $ | 77,500 | | 1,197 | | $ | 597 | | 557,393 | * | $ | 5,574 | * | $ | 46,168,403 | * | $ | 3,857,593 | | $ | (46,819,932 | ) | $ | (131,734 | ) | $ | (604,110 | ) | $ | (140,490 | ) | $ | 2,553,891 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Conversion of convertible debenture | | | | | | | | | | | | 636,571 | | | 6,366 | | | 907,443 | | | | | | | | | | | | | | | | | | 913,809 | |
Reversal of Shares issued for services to be provided | | | | | | | | | | | | (5,000 | ) | | (50 | ) | | (19,840 | ) | | | | | | | | | | | | | | 19,890 | | | (19,890 | ) |
Shares issued for services to be provided | | | | | | | | | | | | 25,500 | | | 255 | | | 47,430 | | | | | | | | | | | | | | | (47,685 | ) | | 47,685 | |
Induced conversion cost | | | | | | | | | | | | | | | | | | 552,370 | | | | | | | | | | | | | | | | | | 552,370 | |
Interest paid with stock | | | | | | | | | | | | 51,527 | | | 515 | | | 93,933 | | | | | | | | | | | | | | | | | | 94,448 | |
Reversal of Common shares issued to officers, directors and employees for fiscal 2009 | | | | | | | | | | | | (144,000 | ) | | (1,440 | ) | | (560,160 | ) | | | | | | | | | | | 561,600 | | | | | | - | |
Common shares issued to officers, directors and employees for fiscal 2009 | | | | | | | | | | | | 720,494 | | | 7,205 | | | 1,338,260 | | | | | | | | | | | | (1,345,465 | ) | | | | | - | |
Amortization officers, directors and employee compensation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 715,242 | | | 23,842 | | | 715,242 | |
Net loss for the Year | | | | | | | | | | | | | | | | | | | | | | | | (2,354,032 | ) | | | | | | | | | | | (2,354,032 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at July 31, 2009 | | 155,000 | | $ | 77,500 | | 1,197 | | $ | 597 | | 1,842,485 | | $ | 18,425 | | $ | 48,527,839 | | $ | 3,857,593 | | $ | (49,173,964 | ) | $ | (131,734 | ) | $ | (672,733 | ) | $ | (144,443 | ) | $ | 2,503,523 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
*Represents retroactive application of 1:5 reverse stock split.
The accompanying notes are an integral part of the consolidated financial statements.
F-5
CONOLOG CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| | | | | | | |
| | 2009 | | 2008 | |
| | | | | |
CASH FLOWS FROM OPERATING ACTIVITIES | | | | | | | |
Net loss | | $ | (2,354,032 | ) | $ | (6,967,606 | ) |
Adjustments to reconcile net loss to net cash used in operations: | | | - | | | | |
Depreciation | | | 23,373 | | | 24,000 | |
Amortization of deferred compensation | | | 715,242 | | | 1,319,400 | |
Amortization of prepaid consulting expense | | | 43,732 | | | 120,600 | |
Write off of discount on converted debt | | | 77,500 | | | 864,892 | |
Induced conversion cost | | | 552,370 | | | 1,387,087 | |
Amortization of deferred loan discount | | | 286,584 | | | 606,598 | |
Amortization of deferred financing fees | | | 123,274 | | | 504,740 | |
Write down of obsolete inventory parts | | | 82,138 | | | 112,171 | |
Changes in assets and liabilities | | | - | | | | |
(Increase) decrease in accounts receivable | | | 114,866 | | | (296,078 | ) |
(Increase) decrease in prepaid expenses | | | (24,476 | ) | | (24,157 | ) |
(Increase) in inventories | | | (627,083 | ) | | (423,824 | ) |
(Increase) decrease in other current assets | | | 16,592 | | | (123,393 | ) |
Increase in accounts payable and accrued expenses | | | 17,042 | | | 104,213 | |
| | | | | | | |
Net cash used in operations | | | (952,878 | ) | | (2,791,357 | ) |
| | | | | | | |
CASH FLOWS FROM INVESTING ACTIVITIES | | | | | | | |
Purchase of property and equipment | | | (311,242 | ) | | - | |
Purchase of certificates of deposit | | | - | | | (3,697,670 | ) |
Redemption of certificates of deposit | | | 600,182 | | | 5,134,818 | |
| | | | | | | |
Net cash used in investing activities | | | 288,940 | | | 1,437,148 | |
| | | | | | | |
CASH FLOWS FROM FINANCING ACTIVITIES | | | | | | | |
Proceeds from issuance of stock and warrants | | | - | | | 1,334,200 | |
Proceeds from note receivable | | | 10,649 | | | 13,645 | |
| | | | | | | |
Net cash provided by financing activities | | | 10,649 | | | 1,347,845 | |
| | | | | | | |
NET (DECREASE) IN CASH AND CASH EQUIVALENTS | | | (653,289 | ) | | (6,364 | ) |
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR | | | 680,647 | | | 687,011 | |
| | | | | | | |
CASH AND CASH EQUIVALENTS - END OF YEAR | | | 27,358 | | | 680,647 | |
| | | | | | | |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | | | | | | | |
CASH PAID DURING THE YEAR FOR: | | | | | | | |
Interest expense | | $ | 7,931 | | $ | 15,323 | |
| | | | | | | |
Income Taxes | | $ | - | | $ | - | |
| | | | | | | |
SUPPLEMENTAL DISCLOSURE OF NONCASH ACTIVITIES: | | | | | | | |
Debt converted to equity | | $ | 913,809 | | $ | 1,873,244 | |
| | | | | | | |
Common stock issued for serices to be provided | | $ | 47,685 | | $ | 19,890 | |
| | | | | | | |
Common stock issued for deferred compensation | | $ | 1,345,465 | | $ | 604,110 | |
| | | | | | | |
Common stock issued for accrued interest | | $ | 94,448 | | $ | 38,198 | |
| | | | | | | |
The accompanying notes are an integral part of the consolidated financial statements.
F-6
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| |
NOTE 1- | NATURE OF ORGANIZATION |
| |
| Conolog Corporation (the “Company”) is in the business of design, manufacturing and distribution of small electronic and electromagnetic components and subassemblies for use in telephone, radio and microwave transmissions and reception and other communication areas. The Company’s products are used for transceiving various quantities, data and protective relaying functions in industrial, utility and other markets. The Company’s customers include primarily industrial customers, which include power companies, and various branches of the military. |
| |
| The Company formed a wholly owned Subsidiary, Nologoc Corporation. In September 1998, Nologoc Corporation purchased the assets of Atlas Design, Incorporated. In January, 2001, Nologoc Corporation purchased the assets of Prime Time Staffing, Incorporated and Professional Temp Solutions Incorporated. Atlas Design, Prime Time Staffing and Professional Temp Solutions provide short-term and long-term qualified engineering and technical staff, as well as human resource consulting to various industries. In March 2004 the Company ceased operating its staffing business. The assets of the Company’s wholly-owned subsidiary, Nologoc, Inc. trading as Atlas Design, were sold to the Company’s vice-president of operations of Atlas Design. |
| |
NOTE 2- | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
| |
| Principles of Consolidation |
| The consolidated financial statements include the accounts of Conolog Corporation and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. |
| |
| Cash and Equivalents |
| For the purpose of the statements of cash flows, cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of twelve months or less. The Company maintains cash and cash equivalents balances at financial institutions and are insured by the Federal Deposit Insurance Corporation up to $250,000. At times during the year, balances in certain bank accounts may exceed the FDIC insured limits. |
| |
| Certificates of Deposits |
| At July 31, 2008, the Company had one six month certificate of deposit totaling $600,182, with interest at a rate of 4.3% which matured September 2008. At July 31, 2009 the Company did not have a certificate of deposit. |
| |
| Inventories |
| Inventories are valued at the lower of cost (determined on a first-in, first-out basis) or market. |
| |
| Property, Plant and Equipment |
| Property, plant and equipment are carried at cost, less allowances for depreciation. Depreciation is computed by the straight-line method over the estimated useful lives of the assets. Depreciation was $23,373 and $24,000 for the years ended July 31, 2009 and 2008, respectively. Repairs and maintenance expenditures which do not extend the useful lives of the related assets are expensed as incurred. |
F-7
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| |
NOTE 2- | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
| (CONTINUED) |
| |
| Research and Development |
| Research and Development costs are expensed as incurred. Research and Development costs were $57,089 and $150,173 for the years ended July 31, 2009 and 2008 respectively. |
| |
| Revenue Recognition |
| Revenue is recorded in accordance with the guidance of the SEC’s Staff Accounting Bulletin (SAB) No. 104, which supersedes SAB No. 101. Revenue from product sales are recognized at the time of shipment (when title and risks and rewards of ownership have passed) upon fulfillment of acceptance terms; products are not sold on a conditional basis. Therefore, when delivery has occurred the sale is complete as long as the collection of the resulting receivable is probable. |
| |
| Receivables and Allowance for Doubtful Accounts |
| The preparation of financial statements requires our management to make estimates and assumptions relating to the collectivity of our accounts receivable. Management specifically analyzes historical bad debts, customer credit worthiness, current economic trends and changes in our customer payment terms when evaluating the adequacy of the allowance for doubtful accounts. The Company has a concentration risk in trade accounts receivable with significant sales to the government and local agencies. The credit evaluation process has mitigated the credit risk, such losses have been minimal, and within management expectations. |
| |
| Other Current Assets |
| In 1998, the State of New Jersey enacted legislation allowing emerging technology and/or biotechnology companies to sell their unused New Jersey Net Operating Loss (“NOL”) Carryover and Research and Development Tax Credits (“R&D” Credits) to corporate taxpayers in New Jersey. During fiscal years ended July 31, 2009 and 2008, the Company entered into agreements to sell its unused NOL’s. Other current assets at July 31, 2009 and 2008 represent the gross proceeds to be received under such contracts. |
| |
| Advertising / Public Relations Costs |
| Advertising/Public Relations costs are charged to operations when incurred. These expenses were $37,521 and $41,795 for the years ended July 31, 2009 and 2008, respectively. |
| |
| Shipping and Handling Costs |
| Shipping and handling costs are expensed as incurred and amounted to $30,583 and $17,491 for the years ended July 31, 2009 and 2008, respectively. |
| |
| Securities Issued for Services |
| The Company accounts for common stock issued for compensation services of Officers, Directors and employees by reference to the fair market value of the Company’s stock on the date of stock issuance. |
| |
| Fair Value of Financial Instruments |
| The carrying amounts of cash, accounts receivable, other current assets, accounts payable and accrued expenses approximates fair value because of the short maturity of these instruments. |
F-8
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| |
NOTE 2- | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
| (CONTINUED) |
| |
| Income Taxes |
| Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the bases of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future federal and state income taxes. |
| |
| Loss Per Share of Common Stock |
| Loss per share of common stock is computed by dividing net loss (after dividends on preferred shares) by the weighted average number of shares of Common Stock outstanding during the year. The preferred dividends are not reflected in arriving at the net loss as they are not material and would have no effect on earnings per share available to common shareholders. The number of weighted average shares used in the computations was 2,396,924 and 296,676 (adjusted for a 1:5 reverse stock split) for 2009 and 2008 respectively. The effect of assuming the exchange of Series A Preferred Stock and Series B Preferred Stock in 2009 and 2008 would be anti-dilutive. |
| |
| Anti-dilutive shares are not included in the calculation of Earnings per Share. |
F-9
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| |
NOTE 2- | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
| (CONTINUED) |
| |
| Loss Per Share of Common Stock (Continued) |
| The effect of assuming the exercise of outstanding warrants at July 31, 2009 would be anti-dilutive. |
| |
| The following is a reconciliation of the computation for basic and diluted EPS: |
| | | | | | | | |
| | | July 31, 2009 | | July 31, 2008 |
| | | | | |
| Net Loss | | $ | (2,354,032 | ) | $ | (6,967,606 | ) |
| | | | | | | | |
| | | | | | | | |
| Weighted-average common shares outstanding (Basic) | | | 2,396,924 | | | 296,676 | * |
| Weighted-average common stock equivalents: | | | | | | | |
| Stock options | | | - | | | - | |
| Warrants | | | - | | | - | |
| | | | | | | | |
| | | | | | | | |
| Weighted-average common shares outstanding (Diluted) | | | 2,396,924 | | | 296,676 | * |
| | | | | | | | |
| *Represents retroactive application of 1:5 reverse stock split. | | | | | | | |
| |
| Use of Estimates |
| The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
F-10
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| |
NOTE 2- | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
�� | (CONTINUED) |
| |
| Recent Accounting Pronouncements |
| In February 2007 the FASB issued Financial Accounting Standards No. 159, The Fair Value Option for Financial Assets and Financial Liabilities – including an amendment of FASB Statement No. 115 effective for financial statements issued for fiscal years beginning after November 15, 2007. This Statement permits entities to choose to measure many financial instruments and certain other items at fair value. The Company does not expect FAS 159 to have a material impact on its results or financial statements. |
| |
| Also in February 2007 the FASB issued Financial Accounting Standards No. 160, Noncontrolling Interests in Consolidated Financial Statements- an amendment of ARB No. 51 effective for financial statements issued for fiscal years beginning after December 15, 2008.. The Company does not expect FAS 160 to have a material impact on its results or financial statements. |
| |
| In March 2008 the FASB issued Financial Accounting Standards No. 161, Disclosures about Derivative Instruments and Hedging Activities – an amendment of FASB No.133 effective for financial statements issued for fiscal years beginning after November 15, 2007.. This Statement requires enhanced disclosures about an entity’s derivatives and hedging activities and thereby improves the transparence of financial reporting. The Company does not expect FAS 161 to have a material impact on its results or financial statements. |
| |
| In May 2009 the FASB issued Financial Accounting Standards No. 165, Subsequent Events, effective for financial statements issued for fiscal years beginning after June 15, 2009. The objective of this Statement is to establish principles and requirements for subsequent events. The Company does not expect FAS 165 to have a material impact on its results or financial statements. |
| |
| In June 2009 the FASB issued Financial Accounting Standards No. 166, Accounting for Transfer of Financial Assets, an amendment of FASB Statement No. 140. The Company does not expect FAS 165 to have a material impact on its results or financial statements. |
| |
| In June 2009 the FASB issued Financial Accounting Standards No. 167, Amendments to FASB Interpretation No. 46(R). The Company does not expect FAS 165 to have a material impact on its results or financial statements. |
| |
| In June 2009 the FASB issued Financial Accounting Standards No. 168, The FASB Accounting Standards Codification and the Hierarchy of GAAP, a replacement of FASB No. 162. The Company does not expect FAS 165 to have a material impact on its results or financial statements. |
F-11
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| |
NOTE 3- | INVENTORY |
| |
| Inventory consisted of the following as of July 31, |
| | | | | | | |
| | | 2009 | | 2008 |
| | | | | |
| Finished Goods | | $ | 841,098 | | $ | 560,903 |
| Work-in-process | | | 38,368 | | | 32,033 |
| Raw materials | | | 515,986 | | | 257,571 |
| | | | | | | |
| | | $ | 1,395,452 | | $ | 850,507 |
| | | | | | | |
| |
NOTE 4- | RENTAL COMMITMENTS |
| Total rental expense for all operating leases of the Company amounted to approximately $55,680 and $55,680 during the years ended July 31, 2009 and 2008, respectively. The Company currently leases its facilities on a month-to-month basis. |
| |
NOTE 5- | DEFERRED FINANCING FEES |
| The Company has deferred financing fees of $8,445 and $295,030 for July 31, 2009 and 2008, respectively. These deferred financing fees will be amortized over the life of the loans. Amortization expense for these fees for the years ended July 31, 2009 and 2008 were $123,274 and $504,740 respectively. |
| |
NOTE 6- | DEFERRED COMPENSATION |
| Pursuant to the Corporation 2008 Stock Incentive Plan, 720,494 common shares of Company stock were issued to current Officers, Directors and Employees during fiscal 2009. These shares were recorded at a value of $1,345,465 and will be expensed during the July 31, 2010 fiscal year. |
| |
NOTE 7- | NOTE RECEIVABLE |
| |
| The Company entered into an Agreement to Rescind Asset Purchase Agreement, dated October 22, 2002. This Agreement requires the repayment of $148,640, consisting of principal and interest accrued to July 31, 2004. Payments of $1,607 (principal of $1,239 and interest at 5% of $368) begin December 30, 2004 and will continue monthly until the full balance is repaid. The balance of this Note at July 31, 2009 was $84,710. |
| |
NOTE 8 - | OTHER CURRENT ASSETS |
| The income tax (benefit) is comprised of the following: |
F-12
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
In 1998, the State of New Jersey enacted legislation allowing emerging technology and/or biotechnology companies to sell their unused New Jersey Net Operating Loss (“NOL”) Carryover and Research and Development Tax Credits (“R&D” Credits) to corporate taxpayers in New Jersey. During fiscal year ended July 31, 2009, the Company entered into an agreement under which it will sell $551,937 of its NOL carryover. The total net proceeds of this transaction will amount to approximately $486,000 and a portion is recorded as other income in the accompanying financial statements.
Deferred taxes are recognized for temporary differences between the bases of assets and liabilities for financial statement and income tax purposes, and net operating losses.
The temporary differences causing deferred tax benefits are primarily due to net operating loss carry forwards. The Company has established a valuation allowance at the full value of the deferred tax asset.
At July 31, 2009 and 2008, the Company has net operating loss carryforwards for federal and state income tax (Book) purposes of approximately $49,000,000 and $46,800,000 respectively, which is available to offset future Federal and State taxable income through 2029.
There was no provision for income taxes for the year ended July 31, 2009 and July 31, 2008.
| | | | | | | |
| | 2009 | | 2008 | |
| | | | | | | |
Deferred tax asset | | | | | | | |
| | $ | 17,150,000 | | $ | 16,380,000 | |
Less: Valuation allowance | | $ | (17,150,000 | ) | $ | (16,380,000 | ) |
| | | | | | | |
| | | | | | | |
| | | - | | | - | |
| |
NOTE 9- PROFIT SHARING PLAN |
| |
| The Company sponsors a qualified profit sharing plan that covers substantially all full time employees. Contributions to the plan are discretionary and determined annually by management. No contributions to the plan were made during the years ended July 31, 2009 and 2008. |
| |
| The Plan also provides an employee savings provision (401(k) plan whereby eligible participating employees may elect to contribute up to the maximum allowed under the IRS code to an investment trust. For tax year 2009 this maximum allowable deferred contribution was $16,500 ($21,500 for employee over age 59 ½). The Company made matching contributions to the plan of $98,893 and $180,619 for the fiscal years ended July 31, 2009 and 2008 respectively. |
F-13
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
NOTE 10- STOCKHOLDERS’ EQUITY
| |
| The Series A Preferred Stock provides 4% cumulative dividends, which were $123,883 ($0.80 per share) in arrears at July 31, 2009. In addition, each share of Series A Preferred Stock may be exchanged for one share of Common Stock upon surrender of the Preferred Stock and payment of $48,000 per share. The Company may redeem the Series A Preferred Stock at $.50 per share plus accrued and unpaid dividends. |
| |
| The Series B Preferred Stock provides cumulative dividends of $0.90 per share, which were $41,016 ($34.27 per share) in arrears at July 31, 2009. In addition, each share of Series B Preferred Stock is convertible into .005 of one share of Common Stock. |
| |
| On January 19, 2006, pursuant to a Subscription Agreement, the Company sold and issued to three Subscribers Convertible Notes having an aggregate principal balance of $1,250,000 which are convertible into 1,000,000 shares of common stock at a conversion price of $1.25 per share, and warrants to purchase 1,000,000 shares of common stock at a price of $0.9579 per share. The Warrants are exercisable as of April 19, 2006 and terminate on the fifth year anniversary date. Interest payable on these notes accrues at a rate of 5% per annum. The convertible notes and warrants have been recorded in compliance with APB-14. |
| |
| The $1,250,000 of proceeds attributed to the Convertible Debenture are recorded based upon their relative fair value. The value assigned to the warrants of $401,363 has been recorded as a discount to the convertible debenture. Additionally, the warrants valued at $0.9579 per share represents a Beneficial Conversion feature calculated at their intrinsic value and amounted to $46,157. This beneficial conversion feature has been recorded as a discount to the convertible debenture. This aggregate discount to the debt of $447,520 will be amortized over the life of the debt using the effective interest method. |
| |
| At a Special Meeting of the shareholders held on August 2, 2006 a proposal to amend the Certificate of Incorporation to give effect to a one-for-six reverse stock split of the common stock of the Company was approved by the stockholders. The reverse split was effected on August 4, 2006. |
| |
| Pursuant to a Subscription Agreement dated January 19, 2006, the Company sold and issued to three Subscribers Convertible Notes having an aggregate principal balance of $1,250,000 which as a result of the reverse split are convertible into 166,667 (the “Note Shares”) post split shares of (post 1-for-6 stock reverse split) common stock at a post split conversion price of $7.50, and warrants to purchase 166,668 shares of (post 1-for-6 stock reverse split) common stock at a post split exercise price of $5.7474 per share (the “Conversion Price”). Pursuant to an agreement dated as of September 28, 2006, between the Company and the selling shareholders who were parties to the January 19, 2006 Subscription Agreement (the “Subscribers”), the Company reduced the warrant exercise price of warrants held by the Subscribers to $1.25 so long as such warrants were exercised by October 31, 2006, after which time the warrant exercise price would revert to $5.7474, subject to adjustment as provided in the warrants. Pursuant to an agreement between the Company and First Montauk Securities Corp. (the placement agent in the private placement with the selling shareholders who were parties to the January 19, 2006 Subscription Agreement) the Company reduced the exercise price of warrants issued to First Montauk Securities Corp. and/or its transferees to $1.25. As of January 31, 2007 all of the Subscribers and some of the First Montauk Securities Corp. warrants, amounting to 191,667 warrants were exercised at a conversion price of $1.25 per share. The Company received a Gross amount of $239,584 for these warrants. |
| |
| As permitted by the January 19, 2006 Subscription Agreement, on November 30th, the Company reduced the Conversion Price to $1.10 per share. Any shares in excess of the Notes Shares will not be registered under the Securities Act of 1933, as amended, and, therefore, may not be offered for sale, pledged or hypothecated in the absence of an effective registration statement or an opinion of counsel reasonably satisfactory to the Company that such registration is not required. |
F-14
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| |
| In January 2007, the Company reduced the original conversion prices of their outstanding debentures from $7.50 to $1.10. Subsequent to the reduction in the conversion price the debt holders exercised their rights to convert. The incremental consideration of the shares issued in the conversion was valued at $2,705,457 and recorded as induced conversion costs in the accompanying statement of operations. |
| |
| In connection with this conversion, the amortization of deferred loan costs of $174,147 and the amortization of deferred loan discount of $363,610 were fully written off. |
| |
| On March 12, 2007 we completed a private placement of an aggregate of $2,825,000, principal amount, of Convertible Debentures with eight investors. The Convertible Debentures are convertible into an aggregate of 1,412,500 shares of the common stock of the Company. |
| |
| The Conversion Price of the Convertible Debentures is $2.00 per share. The investors have also received warrants to purchase an aggregate of 1,412,500 shares of the Company’s common stock at an exercise price of $2.88 per share, exercisable beginning at any time on the sooner of September 8, 2007 or the date the Company’s stockholders approves the issuance of the Company’s common stock issuable on conversion of the Convertible Debentures (if such approval is required by the applicable rules of the Nasdaq) through the fifth anniversary of the issuance. In addition, the selling agent (including certain of its employees and affiliates) was granted a warrant to acquire 282,500 shares of the Company’s common stock. The Company received net proceeds of $2,487,500. The private placement was approved by the Company’s shareholders, as required by applicable Nasdaq rules, on May 15, 2007. |
| |
| On September 7, 2007, the Company’s Board of Directors voted unanimously to adjust the original conversion price of their outstanding debentures from $2.00 to $1.40 resulting in the reduction in Notes payable of $1,246,171. |
| |
| On December 26, 2007, the Company’s Board of Directors voted unanimously to further adjust the original conversion price of their outstanding debentures from $1.40 to $1.05. There has been no reduction in Notes payable as of this filing. |
| |
| On June 12, 2008, the Company’s Board of Directors voted unanimously to adjust the original conversion price of their outstanding debentures from $4.20 (post reversal) to $1.20 resulting in the reduction in Notes payable of $627,071. |
| |
| On November 2, 2007, the Company issued and sold in a private placement (the “Private Placement”), an aggregate of 953,000 shares of common stock (the “Common Shares”) at a purchase price of $1.40 per share, and warrants to purchase 476,500 shares of the Company’s common stock, which are exercisable for a period commencing six months from November 2, 2007 for five years to November 2, 2012, at an exercise price of $1.66 per share (the “Subscriber Warrants”). From the sale of the Common Shares, the Company received net proceeds of $1,163,268 after deducting attorneys’ fees, printing fees and other miscellaneous fees related to the Private Placement. |
| |
| On March 20, 2008 Conolog received a Nasdaq Staff Deficiency Letter stating that, as the bid price of the Company’s common stock has closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Capital Market set forth in Marketplace Rule 4310(c)(4), in accordance with Marketplace Rule 4310(c) (8)(D), the Company will be provided 180 calendar days, or until September 16, 2008, to regain compliance. If at any time before September 16, 2008, the bid price of the Company’s stock closes at $1.00 per share or more for a minimum of 10 consecutive business days Nasdaq will provide written notification that the Company complies with the rule. |
F-15
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| |
| On May 21, 2008, a Special Meeting of the Company’s shareholders approved a proposed amendment to the company’s certificate of incorporation to effect a one-for-four reverse split of the Company’s common stock which was subsequently approved by the Company’s board of directors. |
| |
| On June 25, 2008 Conolog received a Nasdaq Notification Letter stating that the bid price of the Company’s common stock has closed above the minimum $1.00 per share requirement for at least 10 consecutive trading days and accordingly has regained compliance with Marketplace Rule 4310 (c) (4). |
| |
| On August 26, 2008 Conolog received a Nasdaq Staff Deficiency Letter stating that, as the bid price of the Company’s common stock has closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Capital Market set forth in Marketplace Rule 4310(c)(4), in accordance with Marketplace Rule 4310(c) (8)(D), the Company was provided 180 calendar days, or until February 23, 2009, to regain compliance. During that period the Company regained compliance and was provided with notification of compliance from NASDAQ. |
| |
| On February 25, 2009, a the Annual Meeting of the Company’s shareholders approved a proposed amendment to the company’s certificate of incorporation to effect a one-for-five reverse split of the Company’s common stock which was subsequently approved by the Company’s board of directors. |
A summary of the Company’s warrant activity is as follows:
| | | | | | | | | | |
| | | | Year End July 31, | | Weighted average Exercise Price |
| | Number of Original Warrants | | 2008 | | 2009 | |
| | | | |
| | | 1 X 4 | | 1 X 5 | |
| | | | | | | | |
Balance st July 31, 2004 | | 470,000 | | | | | | $ | 1.69 | |
Exercised September 2004 | | (270,000 | ) | | | | | $ | 1.59 | |
| | | | | | | | | | |
| | 200,000 | | 8,333 | | 1,667 | | $ | 202.80 | |
| | | | | | | | | | |
| | | | | | | | | | |
Issued February 2005 | | 958,549 | | | | | | $ | 1.25 | |
Exercised February 2005 | | (200,000 | ) | | | | | $ | 1.84 | |
| | | | | | | | | | |
| | 758,549 | | 31,606 | | 6,321 | | $ | 150.00 | |
| | | | | | | | | | |
Issued July 2005 | | 1,440,000 | | 60,000 | | 12,000 | | $ | 40.56 | |
| | | | | | | | | | |
Issued January 2006 | | 1,200,000 | | | | | | $ | 0.96 | |
Exercised February 2007 | | (1,191,667 | ) | | | | | | | |
| | | | | | | | | | |
| | 8,333 | | 2,083 | | 417 | | $ | 25.00 | |
| | | | | | | | | | |
Issued March 2007 | | | | 423,750 | | 84,750 | | $ | 57.60 | |
Issued November 2007 | | | | 119,125 | | 23,825 | | $ | 33.20 | |
| | | | | | | | | | |
| | | | | | | | | | |
Balance July 31, | | | | 644,897 | | 128,979 | | $ | 3.83 | |
| | | | | | | | | | |
| |
| NOTE -11 CONVERTIBLE DEBENTURES |
| |
| On March 12, 2007 a private placement of an aggregate of $2,825,000, principal amount, of Convertible Debentures was placed with eight investors. The Convertible Debentures are convertible into an aggregate of 1,412,500 shares of the common stock of the Company. |
| |
| The balance of any un-converted note with simple and unpaid interest (at 6%) will mature on March 12, 2009. |
F-16
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
The Conversion Price of the Convertible Debentures is $2.00 per share. The investors have also received warrants to purchase an Aggregate of 1,412,500 shares of the Company’s common stock at an exercise price of $2.88 per share, exercisable beginning at any time on the sooner of September 8, 2007 or the date the Company’s stockholders approves the issuance of the Company’s common stock issuable on conversion of the Convertible Debentures (if such approval is required by the applicable rules of the Nasdaq) through the fifth anniversary of the issuance. In addition, the selling agent (including certain of its employees and affiliates) was granted a warrant to acquire 282,500 shares of the Company’s common stock.
The Company received net proceeds of $2,487,500.
On September 7, 2007, the Company’s Board of Directors voted unanimously to adjust the original conversion price of their outstanding debentures from $2.00 to $1.40 resulting in the reduction in Notes payable of $ 1,246,171.
On December 26, 2007, the Company’s Board of Directors voted unanimously to further adjust the original conversion price of their outstanding debentures from $1.40 to $1.05. There has been no reduction in Notes payable as of this filing. On June 12, 2008, the Company’s Board of Directors voted unanimously to adjust the original conversion price of their outstanding debentures from $4.20 (post reversal) to $1.20 resulting in the reduction in Notes payable of $627,071.
On September 8, 2008, The Company has reduced the exercise price of the warrants issued in connection with the Subscription Agreement, dated March 12, 2007 (the “Subscription Agreement”), from $1.20 per share to $0.50 per share. As a result of the reduction of the warrant exercise price, pursuant to Section 12 (b) of the Subscription Agreement, the conversion price of the Convertible Notes issued in connection with the Subscription Agreement is now $0.50 per share. Any shares in excess of the shares that already have been registered for sale on conversion of the Notes will not be registered under the Securities Act of 1933, as amended, and, therefore, may not be offered for sale, pledged or hypothecated in the absence of an effective registration statement or an opinion of counsel reasonably satisfactory to the Company that such registration is not required. As a result of the above reductions in exercise and conversion prices, as of October 15, 2008 investors have converted $285,042 of debt for 570,084 common stock shares. The Company recognized an Induced Conversion cost related to these conversions of approximately $180,500.
On March 9, 2009, the Company and holders of its outstanding Convertible Notes agreed that the Maturity Date of the Notes shall be August 31, 2009; the holders of the Notes may convert any principal amount or interest remaining on the Note at an applied conversion rate equal to the lessor of (A) the Fixed Conversion Price or (B) seventy-five percent of the average closing bid price of the Common Stock for the five trading days preceding the date of Notice of Conversion.
The balance of these Convertible debentures at July 31, 2009 was $ 37,950. This final note was converted on August 18, 2009.
| |
NOTE 12- | MAJOR CUSTOMERS |
| |
| The following summarizes sales to major customers (each 10% or more of net sales) by the Company: |
| | | | | | | | | | | | | |
Year Ended | | Total Revenue | | Sales to Major Customers | | Number of Customers | | Percentage of Total | |
| | | | | | | | | |
2009 | | $ | 1,485,298 | | $ | 946,672 | | 3 | | | 63.7 | % | |
2008 | | $ | 1,220,993 | | $ | 756,137 | | 4 | | | 61.9 | % | |
F-17
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| |
NOTE 13- | STOCK OPTION PLAN |
| |
| 2002 Stock Option Plan |
| |
| On April 23, 2002, the Board of Directors of the Company adopted the 2002 Stock Option Plan (“the 2002 Plan”). Under the 2002 Plan, the Company may grant up to 190,000 shares of common stock as either incentive stock options under Section 422A of the Internal Revenue Code or nonqualified stock options. Subject to the terms of the 2002 Plan, options may be granted to eligible persons at any time and under such terms and conditions as determined by the 2002 Stock Option Committee (‘the Committee”). Unless otherwise determined by the Committee, each stock option shall terminate no later than ten years (or such shorter time as may be fixed by the Committee) after the date in which it was granted. The exercise price for incentive stock options must be at least one hundred percent (100%) of the fair market value of common stock as determined on the date of the grant. The exercise price for nonqualified stock options may not be granted at less than eighty-five percent (85%) of the fair market value of the shares on the date of grant. |
| |
| As of July 31, 2009 and 2008, there had been no shares granted under the 2002 Plan. |
| |
NOTE 14- | SECURITIES ISSUED FOR SERVICES |
| |
| During fiscal year July 31, 2009, the Company issued 25,500 shares of common stock to a consultant for services. These shares were for services that extend into the future and are amortized against invoices billed by the consultants for actual services rendered in fiscal year 2010. |
| |
| During fiscal year July 31, 2008, the Company issued 25,000 shares of common stock to a consultant for services. These shares were for services that extend into the future and are amortized against invoices billed by the consultants for actual services rendered in fiscal year 2009. |
| |
| These services will be performed in fiscal year 2010 and expensed at their fair value of consideration received at the date of the agreement in accordance with EITF 00-18 “Accounting Recognition for Certain Transactions Involving Equity Instruments Granted to Other Than Employees”. |
| |
NOTE 15- | CONTINGENCIES |
| |
| Meyers Associates, L.P. v. Conolog Corporation, Supreme Court of the State of New York, County of New York Index No. 600824/07. |
| |
| On March 13, 2007, Meyers Associates, L.P. commenced an action against Conolog Corporation, asserting that: (1) Conolog breached a purported contract it had with Meyers pursuant to which it claims Meyers was to act as lead underwriter in connection with a Regulation D securities offering for Conolog, and (2) Conolog misappropriated a purported confidential list of potential investors. Conolog denies the allegations in the complaint and intends to vigorously defend against Meyers’s claims. |
F-18
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| |
| On May 7, 2009, The Supreme Court of New York issued a Stipulation of Dismissal, dismissing all claims asserted by Meyers Associates, with prejudice. |
| |
| Allen Wolfson v. Conolog Corporation, United States District Court for the Southern District of New York, Case Number 08-cv-3790. |
| |
| On April 22, 2008, Allen Wolfson filed an action against Conolog Corporation, asserting that there was a breach of contract in connection with four consulting contracts allegedly entered into with “plaintiff and entities controlled by plaintiff.” On June 10, 2008, the company filed a motion to dismiss Plaintiff’s complaint on the grounds that the Court lacks personal jurisdiction over the Company or, in the alternative, for Plaintiff’s failure to state a claim upon which relief can be granted. A Stipulation of Dismissal was issued during July 2009. |
| |
NOTE 16– | RECLASSIFICATION |
| |
| Certain reclassifications have been made to the July 31, 2008 consolidated financial statements to conform to the 2009 presentation. These had no effect on net loss or cash flow for the year ended July 31, 2008. |
| |
NOTE 17- | SUBSEQUENT EVENTS |
| |
| Conolog Corporation (the “Company”) entered into a Subscription Agreement (the Subscription Agreement”), dated as of August 3, 2009 ( the “Closing Date”), with three investors, pursuant to which it sold an aggregate of One Million Dollars of its principal amount of secured promissory notes (the “Notes”). On the Closing Date the Company received gross proceeds of $500,000 and $500,000 (the “Escrowed Funds”) was placed in escrow pursuant to an Escrow Agreement between the Company, the Subscribers and Grushko & Mittman, as escrow agent. Pursuant to the Subscription Agreement, the Company must file a preliminary proxy statement with the Securities and Exchange Commission by September 2, 2009 seeking approval for the transactions contemplated by the Subscription Agreement and the Company must obtain approval of its shareholders within 90 days of the Closing Date (125 days if the SEC reviews the proxy statement.). Provided shareholder approval is obtained (the “Shareholder Approval”), the Company will receive the Escrowed Funds. In the event that the Shareholder Approval is not obtained (“Shareholder Rejection”), the amount of the Note will decrease to $500,000 and the Escrowed Funds will be returned to the Subscribers. The initial interest rate of the Notes is 4% per annum and upon the shareholder Approval or a Rejection the interest rate will be 8% per annum. Interest shall accrue from the date of the Closing Date and shall be payable quarterly, in arrears, commencing six months after the Closing Date and on the maturity date of the Note. The Conversion Price of the Notes is the lessor of $.78 (the “Fixed Conversion Price”) as may be adjusted (the “Initial Conversion Price”). Commencing six months after the Closing Date, the Conversion Price shall be the lessor of the Fixed Conversion Price or 75% of the lowest three closing bid prices for the Company’s common stock for the ten days prior to when the Note is converted. |
| |
| The Company also issued the Subscribers Class A Warrants to purchase 1,282,051 shares of the Company’s Common Stock at $1.12 per share. The Class A warrants are exercisable for a period beginning on August 3, 2009 and terminate on August 3, 2014. Pursuant to the Subscription Agreement, the Company also issued the Subscribers a total of 40,000 class B Warrants. |
| |
| The Class B Warrants entitles the Subscribers at any time after the sooner of six months from the Closing Date or after the Company obtains the Approval until July 3, 2012, to purchase up to $4,000,000 of principal amount of the Company’s 8% notes on the same terms as the Notes and 1,000 warrants to purchase 128,205 shares of the Company’s Common Stock at a per share purchase price equal to the lessor of 105 % of the closing bid price of the Company’s common stock or the exercise price of the Class A Warrants. |
F-19
CONOLOG CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED JULY 31, 2009 AND 2008
| |
| For each $100,000 of principal of notes purchased pursuant to the Class B Warrants, the Subscribers will surrender 1,000 Class B Warrants. |
| |
| The Notes cannot be converted to the extent such conversion would cause the Subscriber, together with such holder’s affiliates, to beneficially own in excess of 4.99% of the of the Company’s outstanding common stock immediately following such conversion.
The Company also entered into a Security Agreement pursuant to which it granted the Subscribers a security interest in its assets.
The security interest granted pursuant to the Security Agreement will terminate when the Approval is obtained or the Notes, including outstanding interest due thereon) are repaid. |
| |
| The Company paid Garden State Securities, Inc., the selling agent for this transaction, a cash fee of $100,000 (10% of the aggregate gross proceeds received by the Company) and issued Garden State (or its employees) warrants to purchase 256,410 shares of the Company’s common stock (20% the shares issuable to the subscribers upon conversion of the Notes). |
| |
| Immediately after the closing for the sale of the Notes, 1,841,491 shares of the Company’s common stock were issued and outstanding. |
| |
| At a Special Meeting of Shareholders held on September 24, 2009, the Shareholder Approval was obtained. As a result, the Escrowed Funds were released and after the payment of fees in the amount of $50,000 to Garden State Securities, Inc., the placement agent for the transaction, the Company received net proceeds of $450,000 (prior to the deduction of other fees and expenses related to the Offering). |
| |
| At the Special Meeting of Shareholders held on September 24, 2009, Shareholder approval was obtained for the Company’s 2009 Restrictive Stock Incentive Plan. |
| |
| On September 28, 2009, the Company entered into an Advisory Service Agreement with Garden State Securities Inc. (GSS) to perform certain Advisory and Business services. The Board of Directors has approved the Company to issue 200,000 restricted common shares to GSS. |
| |
| On October 21, 2009, Two holders of the Company’s outstanding Convertible Notes dated August 3, 2009 converted principal amounts of $221,256 and interest amounts of $3,855 and issued a total of 288,605 restricted common shares. |
| |
| After the above transactions, 3,180,846 shares of the Company’s common stock were issued and outstanding. |
F-20
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
| |
Item 13. | Other Expenses of Issuance and Distribution COMPANY PROVIDE |
We will pay all expenses in connection with the registration and sale of the common stock by the selling shareholders. The estimated expenses of issuance and distribution are set forth below.
| | | | |
SEC filing fee | | $ | 69 | .46 |
Legal expenses | | $ | 30,000 | |
Accounting expenses | | $ | 5,000 | * |
| | | | |
Miscellaneous | | $ | 5,000 | * |
Total | | $ | 40,069 | .46 |
*Estimate | | | | |
| |
Item 14. | Indemnification of Directors and Officers |
Our Certificate of Incorporation provides that we shall, to the fullest extent permitted by Section 145 of the Delaware General Corporation Law, as amended from time to time, indemnify all persons whom it may indemnify pursuant thereto.
Section 145 of the General Corporation Law of the State of Delaware authorizes a corporation to provide indemnification to a director, officer, employee or agent of the corporation, including attorneys’ fees, judgments, fines and amounts paid in settlement, actually and reasonably incurred by him in connection with such action, suit or proceeding, if such party acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful as determined in accordance with the statute, and except that with respect to any action which results in a judgment against the person and in favor of the corporation the corporation may not indemnify unless a court determines that the person is fairly and reasonably entitled to the indemnification. Section 145 further provides that indemnification shall be provided if the party in question is successful on the merits.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or controlling persons of the Company, pursuant to the foregoing provisions, or otherwise, the Company has been advised that, in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered hereunder, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
| |
Item 15. | Recent Sales of Unregistered Securities |
We entered into a Subscription Agreement (the “Subscription Agreement”), dated as of August 3, 2009, with three investors, pursuant to which it sold an aggregate of One Million Dollars of our principal amount of secured convertible notes (the “Notes”).
The Conversion Price of the Notes is $.78 but in no event greater than $1.00 per share as the same may be adjusted (the “Fixed Conversion Price”). Commencing on February 3, 2010, the Conversion Price shall be the lessor of the Fixed Conversion Price or 75% of the lowest three closing bid prices for our common stock for the ten days prior to when the Note is converted.
We also issued the Subscribers Class A Warrants to purchase 2,564,103 shares of the Company’s Common Stock at $1.12 per share. The Class A warrants are exercisable for a period beginning on August 3, 2009 and terminate on August 3, 2014.
Pursuant to the Subscription Agreement, we also issued the Subscribers a total of 40,000 class B Warrants. The Class B Warrants entitles the Subscribers, until July 3, 2012, to purchase up to $4,000,000 of principal amount of our 8% notes on the same terms as the Notes. Upon the exercise of the Class B Warrants, the holder of the Class B Warrant will be issued two Class C Warrants for Each share of the Company’s common stock that would be issued on the exercise date of the Class B Warrant assuming the full conversion of the notes issued on such date. For each $100,000 of principal of notes purchased pursuant to the Class B Warrants, the Subscribers will surrender 1,000 Class B Warrants.
The Notes cannot be converted to the extent such conversion would cause the Subscriber, together with such holder’s affiliates, to beneficially own in excess of 4.99% of the of the Company’s outstanding common stock immediately following such conversion.
II - 1
In connection with the sale of the note we issued the placement agent in the transaction (or its employees) warrants to purchase 256,410 shares of the Company’s common stock.
The issuance and sale of the Notes and warrants pursuant to the Subscription Agreement was made in reliance upon the exemption provided in Section 4(2) of the Securities Act and Regulation D promulgated under the Securities Act. No form of general solicitation or general advertising was conducted in connection of the Private Placement. The issuance of the warrant to the selling agent (including its employees and affiliates) was made in reliance upon the exemption provided in Section 4(2) of the Securities Act.
On October 8, 2009 we issued 200,000 shares of our restricted stock in pursuant to a consulting agreement. The issuance and sale of the theses securities was made in reliance upon the exemption provided in Section 4(2) of the Securities Act. No form of general solicitation or general advertising was conducted in connection with the issuance of the securities. The issuance and sale of the theses securities was made in reliance upon the exemption provided in Section 4(2) of the Securities Act. No form of general solicitation or general advertising was conducted in connection with the issuance of the securities.
Pursuant to a Subscription Agreement between us and seven subscribers (the “Subscribers”), dated as of November 3, 2007 (the “Subscription Agreement”), we issued and sold in a private placement 953,000 shares of common stock (the “Common Shares”) at a purchase price of $1.40 per share, and warrants to purchase 476,500 shares of our common stock at a price of $1.66 per share, which are exercisable for a period commencing six months from the issue to five years from the issue date. From the sale of the Common Shares, we received net proceeds of $1,163,438 after deducting our attorneys’ fees, printing fees and other miscellaneous fees related to the private placement. We also issued the selling agent in this transaction iincluding its employees and affiliates, warrants to purchase an aggregate of 190,600 shares of our common stock, and Grushko & Mittman, P.C., the Subscribers’ counsel, including its members (“Grushko”), warrants to purchase an aggregate of 10,000 shares of our common stock.
The issuance and sale of the Common Shares and warrants pursuant to the Subscription Agreement was made in reliance upon the exemption provided in Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”) and Regulation D promulgated under the Securities Act. No form of general solicitation or general advertising was conducted in connection with the private placement. Each of the warrants and the certificates representing the Common Shares issued pursuant to the Subscription Agreement contain restrictive legends preventing the sale, transfer or other disposition of such Common Shares and warrants unless registered under the Securities Act or pursuant to an exemption from such registration. Any shares of our common stock issued pursuant to the warrants shall also contain restrictive legends preventing the sale, transfer or other disposition of such shares unless registered under the Securities Act.
On March 12, 2007, pursuant to a Subscription Agreement between us and eight subscribers (the “Subscribers”), dated as of March 12, 2007 (the “March 12, 2007 Subscription Agreement”), we issued and sold in a private placement Convertible Notes having an aggregate principal balance of $2,825,000 which were convertible into 1,412,500 shares of our common stock at the initial conversion price of $2.00 per share, and warrants to purchase 1,412,500 shares of our common stock at an exercise price of $2.88 per share, which are exercisable for a period of five years from the issue date.
The sale of the Convertible Notes, including the issuance of our common stock pursuant to the convertible notes and the warrants was approved by our board of directors, and on May 15, 2007 our shareholders approved the execution of the March 12, 2007 Subscription Agreement and the related documents. From the sale of the convertible notes, we received net proceeds of $2,487,500 after deducting our attorneys’ fees, printing fees and other miscellaneous fees related to the private placement. We also issued First Montauk, the selling agent, including its employees and affiliates, warrants to purchase an aggregate of 282,500 shares of our common stock. The Company, pursuant to the March 12, 2007 Subscription Agreement
The issuance and sale of the convertible notes and warrants pursuant to the March 12, 2007 Subscription Agreement was made in reliance upon the exemption provided in Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”) and Regulation D promulgated under the Securities Act. No form of general solicitation or general advertising was conducted in connection with the private placement. Each of the Convertible Notes and warrants issued pursuant to the March 12, 2007 Subscription Agreement contain restrictive legends preventing the sale, transfer or other disposition of such Convertible Notes and warrants unless registered under the Securities Act. Any shares of our common stock issued pursuant to the Convertible Notes or warrants shall also contain restrictive legends preventing the sale, transfer or other disposition of such shares unless registered under the Securities Act.
On January 19, 2006 the Company entered into a Subscription Agreement (the “January 19, 2006 Subscription Agreement”), with three subscribers relating to the issuance and sale in a private placement by us of $1,250,000 principal amount of convertible notes, which were convertible into 166,667 shares of our common stock at the initial conversion price of $7.50 per share, and warrants to purchase 166,667 shares of our common stock at an initial exercise price of $5.7474 per share, which are exercisable for a period commencing on the sooner of July 18, 2006 or the date the Company’s stockholders approve the issuance of the Company’s common stock issuable on conversion of the convertible notes (if such approval is required by the applicable rules of
II - 2
the Nasdaq) through the fifth anniversary of the issuance. We also issued First Montauk Securities Corp., the selling agent, warrants to purchase an aggregate of 200,000 shares of our common stock on the same terms and conditions as the warrants issued to the Subscribers. The issuance and sale of the convertible notes and warrants pursuant to the January 19, 2006 Subscription Agreement was made in reliance upon the exemption provided in Section 4(2) of the Securities Act and Regulation D promulgated under the Securities Act. No form of general solicitation or general advertising was conducted in connection with the Private Placement. The issuance of the warrant to First Montauk (including its employees and affiliates) was made in reliance upon the exemption provided in Section 4(2) of the Securities Act. Each of the convertible notes and warrants issued pursuant to the Subscription Agreement contain restrictive legends preventing the sale, transfer or other disposition of such shares and warrants, unless registered under the Securities Act. The Company, pursuant to the January 19, 2006 Subscription Agreement, filed an Amendment No. 1 to Registration Statement on Form SB-2 on April 26, 2006, to register the shares of its common stock issuable upon conversion of the convertible notes, shares of its common stock issuable in payment of interest due on the convertible notes and shares of its common stock issuable upon the exercise of warrants.
II - 3
On October 8, 2009 we authorized the issuance of 800,000 shares of our restricted common stock to our employees, directors, officers and certain consultants to the Company.
Index of Exhibits
| |
Exhibit No. | Description of Exhibits |
3.1 | Certificate of Incorporation - incorporated by reference to the Registrant’s Exhibit 3.01 to Registration Statement on Form S-1 (File No. 2-31302). |
3.1.1 | Certificate of Amendment of Certificate of Incorporation - incorporated by reference to Exhibit 3.02 to the Registrant’s Registration Statement on Form S-1 (File No. 2-31302). |
3.1.2 | Certificate of Amendment of Certificate of Incorporation incorporated by reference to Exhibit 4 to the Registrant’s Current Report on Form 8-K for July 1971. |
3.1.3 | Certificate of Ownership and Merger with respect to the merger of Data Sciences (Maryland) into the Registrant and the change of Registrant’s name from “Data Sciences Incorporated” to “DSI Systems, Inc.” - incorporated by reference to Exhibit 3.03(a) to the Registrant’s Registration Statement on Form S-1 (File No. 2-31302). |
3.1.4 | Certificate of the Designation, Preferences and Relative, Participating, Option or Other Special Rights and Qualifications, Limitations or Restrictions thereof of the Series A Preferred Stock (par value $.50) of DSI Systems, Inc. - incorporated by reference to Exhibit 3.04 to the Registrant’s Registration Statement on Form S-1 (File No. 2-31302). |
3.1.5 | Certificate of the Designation, Preferences and Relative, Participating, Option or Other Special Rights and Qualifications, Limitations or Restrictions thereof of the Series B Preferred Stock (par value $.50) of DSI Systems, Inc. - incorporated by reference to Exhibit 1 to the Registrant’s Current Report on Form 8-K for November 1972. |
3.1.6 | Certificate of Ownership and Merger respecting merger of Conolog Corporation into the Registrant and the changing of the Registrant’s name from “DSI Systems, Inc.” to “Conolog Corporation” - incorporated by reference to Exhibit 3 to the Registrant’s Current Report on Form 8-K for June 1975. |
3.2 | Amended By-Laws - incorporated by reference to Exhibit 3(h) to the Registrant’s Annual Report on Form 10-K for the fiscal year ended July 31, 1981. |
4.1 | Specimen Certificate for shares of Common Stock (1) |
II - 4
| |
4.2 | Form of common Stock Purchase Warrant, dated January 19, 2006 (2) |
4.3 | Form of Convertible Note, dated January 19, 2006 (2) |
4.4 | Form of Common Stock Purchase Warrant, dated March 12, 2007 (3) |
4.5 | Form of Convertible Note, dated March 12, 2007 (3) |
4.6 | Form of Broker’s Common Stock Purchase Warrant, dated March 12, 2007 (3) |
4.7 | Form of Notes as of August 3, 2009 (6) |
4.8 | Form of Class A Warrants (6) |
4.9 | Form of Class B Warrants (6) |
4.10 | Form of Class C Warrants (6) |
5.1 | Opinion Sichenzia Ross Friedman Ference LLP |
10.1 | Employment Agreement dated June 1, 1997 between Robert Benou and Conolog Corporation (4) |
10.2 | Employment Agreement dated June 1, 1997 between Marc Benou and Conolog Corporation (4) |
10.3 | Conolog Corporation 2002 Stock Option Plan (5) |
10.4 | Subscription Agreement dated as of January 19, 2006, among Conolog Corporation and the subscribers named therein (2) |
10.5 | Form of Selling Agent Agreement, dated as of January 18, 2006 (2) |
10.6 | Subscription Agreement dated as of March 12, 2007 (3). |
10.7 | Form of Subscription Agreement between Conolog Corporation and the subscribers named therein dated as of August 3, 2009 (6) |
10.8 | Security Agreement dated as of August 3, 2009 (6) |
II - 5
| | |
21.1 | List of Subsidiaries |
23.1 | Consent of Begell, Josephs, Levine & Company, LLC * |
23.2 | Consent of Sichenzia Ross Friedman Ference LLP (included in Exhibit 5.1) |
| |
|
| |
* | Filed herewith |
| |
(1) | Incorporated by reference to Registrant’s Registration Statement on Form S-1 (File No. 33-92424). |
| |
(2) | Incorporated by reference to Registrant’s Report on Form 8-K filed on January 25, 2006. |
| |
(3) | Incorporated by reference to Registrant’s Report on Form 8-K filed on March 14, 2007 |
| |
(4) | Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (File No. 0-8174) as filed on September 12, 1997. |
| |
(5) | Incorporated by reference to the Registrant’s Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 filed on June 25, 2003. |
| |
(6) | Incorporated by reference to the Registrant’s Report on Form 8-K filed on August 6, 2009. |
| |
1. The undersigned registrant hereby undertakes to file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
| |
| (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933. |
| |
| (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement. |
| |
| (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. |
| |
| Provided, however, that paragraphs (B)(1)(i) and (B)(1)(ii) of this section do not apply if the registration statement is on Form S-3, Form S-8 or Form F-3, and the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement. |
| |
2. The undersigned registrant hereby undertakes that, for the purpose of determining any liability under the Securities Act of 1933, as amended, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
II - 6
3. The undersigned registrant hereby undertakes to remove from registration by means of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering.
4. The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
5. The undersigned registrant hereby undertakes that, for the purposes of determining liability to any purchaser:
(i) If the registrant is relying on Rule 430B:
(A) For purposes of determining liability under the Securities Act of 1933, each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or
(ii) If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.
6. Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended, may be permitted to directors, officers and controlling persons of the undersigned registrant according the foregoing provisions, or otherwise, the undersigned registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933, as amended, and will be governed by the final adjudication of such issue.
II - 7
SIGNATURES
In accordance with the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of New York, State of New York, on December 8, 2009.
| | |
| CONOLOG CORPORATION |
| A Delaware corporation |
| | |
| By: | /s/ Robert Benou |
| |
|
| | Robert Benou |
| Its: | Chief Executive Officer |
| | (Principal Executive Officer, Principal |
| | Financial Officer and Principal |
| | Accounting Officer) |
| |
| In accordance with the requirements of the Securities Act, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated. |
| | | | |
Signature | | Capacities | | Date |
| |
| |
|
| | | | |
/s/ Robert S. Benou | | | | |
| | Chief Executive Officer, and Chairman | | |
Robert S. Benou | | (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) | | December 8, 2009 |
| | | | |
/s/ Marc R. Benou | | | | |
| | President, Chief Operating Officer and Director | | December 8, 2009 |
Marc R. Benou | | | | |
| | | | |
/s/ Louis S. Massad* | | | | |
| | Director | | December 8, 2009 |
Louis S. Massad | | | | |
| | | | |
/s/ Edward J. Rielly* | | | | |
| | Director | | December 8, 2009 |
Edward J. Rielly | | | | |
| | | | |
/s/ David M. Peison* | | | | |
| | Director | | December 8, 2009 |
David M. Peison | | | | |
| | |
| | |
*By: | /s/ Robert Benou | |
| Robert Benou Attorney-in-fact |
II - 8